| Thyroid Hormones in CKD (NCT07663773) | Mario Negri Institute for Pharmacological Research | 2026-09-01 |
| Mitigating Mitochondrial RNA Release During Aging to Control Inflammation and Senescence (NCT07596615) | Mario Negri Institute for Pharmacological Research | 2026-09-01 |
| Implementation of New Models of Ovarian Carcinoma Resistant to Therapy (NCT07757711) | Mario Negri Institute for Pharmacological Research | 2026-08-01 |
| Emergency and Urgent Care Indicators in Piedmont (NCT07606209) | Mario Negri Institute for Pharmacological Research | 2026-07-01 |
| Pragmatic Study to Optimize Neoadjuvant Treatment and Surgical De-escalation in HR+/HER2- Early Breast Cancer Using Oncotype DX and Abemaciclib (NCT07428018) | Mario Negri Institute for Pharmacological Research | 2026-04-30 |
| Omics of Rituximab-resistance (NCT07416942) | Mario Negri Institute for Pharmacological Research | 2026-04-01 |
| AVF-MONITOR POC Proof-of-concept Study (NCT07318025) | Mario Negri Institute for Pharmacological Research | 2026-03-01 |
| Obinutuzumab in Adult Rituximab-Dependent Nephrotic Syndrome (NCT07233330) | Mario Negri Institute for Pharmacological Research | 2026-02-01 |
| Mechanisms Underlying SGLT2i Kidney Effect in DKD Progression (NCT07270198) | Mario Negri Institute for Pharmacological Research | 2026-02-01 |
| Mild TBI in the Emergency Department (NCT07021118) | Mario Negri Institute for Pharmacological Research | 2026-01-21 |
| Evaluation of the Quality of Care in the Emergency Department by Studying the Appropriateness of Hospitalizations (NCT06846879) | Mario Negri Institute for Pharmacological Research | 2026-01-05 |
| RESOLving INflammation Through Diet for Health (RESOLVIN) (NCT07331103) | Mario Negri Institute for Pharmacological Research | 2025-11-26 |
| A New Crowding Indicator in the Emergency Department (NCT07111624) | Mario Negri Institute for Pharmacological Research | 2025-10-15 |
| Effect of B-cell Depleting Therapies on PLA2R-specific B Cells in Patients With Membranous Nephropathy (NCT06994468) | Mario Negri Institute for Pharmacological Research | 2025-09-22 |
| Development of a Multipurpose Dashboard to Monitor the Situation of Emergency Departments (NCT06372379) | Mario Negri Institute for Pharmacological Research | 2025-09-22 |
| Phase II Study of Radiotherapy Followed by Durvalumab and Ceralasertib in Stage III NSCLC Patients With Thoracic Relapses +/- Oligometastases After PACIFIC Regimen (NCT06680050) | Mario Negri Institute for Pharmacological Research | 2025-08-07 |
| Patiromer and Diet/hrQoL in Chronic Dialysis (NCT06858280) | Mario Negri Institute for Pharmacological Research | 2025-07-08 |
| Simulated and Synthetic Health Data: Improving Clinical Research on Rare Diseases. A Real-World Data Simulation of Autosomal Dominant Polycystic Kidney Disease (ADPKD) Trials. A Retrospective, Observational Study (NCT07016282) | Mario Negri Institute for Pharmacological Research | 2025-06-12 |
| New Advanced Vascular Imaging Ultrasound Protocols (NCT06841887) | Mario Negri Institute for Pharmacological Research | 2025-05-09 |
| Reproducibility of Multiparametric Renal Magnetic Resonance Imaging on 1.5T MRI Scanners (NCT06884410) | Mario Negri Institute for Pharmacological Research | 2025-04-12 |
| Comparing the Performance of Serum Creatinine and Cystatin C-based GFR Estimations in Predicting Directly Measured GFR in Patients With or Without Nephrotic Syndrome (NCT06797609) | Mario Negri Institute for Pharmacological Research | 2025-04-01 |
| Blood Flow Conditions and Sounds in AVFs (NCT06411353) | Mario Negri Institute for Pharmacological Research | 2025-03-01 |
| A Possible Founding PKD2 Mutation Associated With Variable Phenotypes of ADPKD in Bergamo Province (NCT06594367) | Mario Negri Institute for Pharmacological Research | 2025-01-22 |
| Medical Images Collection Research (NCT06354829) | Mario Negri Institute for Pharmacological Research | 2025-01-07 |
| An Outcome Analysis of Primary Membranous Nephropathy (NCT06242327) | Mario Negri Institute for Pharmacological Research | 2024-11-29 |
| Artificial Intelligence-based Techniques to Characterize KIdney Microstructure on Histological ImagEs (NCT06690190) | Mario Negri Institute for Pharmacological Research | 2024-11-08 |
| Kidney Perfusion With or Without Absorption (NCT06374121) | Mario Negri Institute for Pharmacological Research | 2024-10-22 |
| Trauma Molecular Processes (NCT07683169) | Mario Negri Institute for Pharmacological Research | 2024-10-18 |
| Artificial Intelligence-based Image Processing Methods to Advance the Characterization of Polycystic Kidney Disease (NCT06688981) | Mario Negri Institute for Pharmacological Research | 2024-10-12 |
| Development of a Natural Language Processing Tool to Enable Clinical Research in Emergency Medicine (NCT06240572) | Mario Negri Institute for Pharmacological Research | 2024-10-01 |
| 1 vs 7 RATG Infusions in Renal Transplantation (NCT06374095) | Mario Negri Institute for Pharmacological Research | 2024-07-30 |
| Autoantibodies Against-nephrin in Idiopathic Nephrotic Syndrome (NCT06334692) | Mario Negri Institute for Pharmacological Research | 2024-03-19 |
| Outcome of ADPKD With Octreotide LAR (NCT06193616) | Mario Negri Institute for Pharmacological Research | 2024-02-12 |
| MuLtidimensional School-based and Family interVentions to Promote hEalthy and Sustainable LifestYle for the Childhood (NCT05966051) | Mario Negri Institute for Pharmacological Research | 2023-10-18 |
| Reduction Of Dietary Salt Intake To Control Systolic Blood Pressure In Hypertensive Older Patients (NCT05976477) | Mario Negri Institute for Pharmacological Research | 2023-10-01 |
| First Line Treatment With Olaparib in Combination With Bevacizumab in HRD Positive Patients (NCT06121401) | Mario Negri Institute for Pharmacological Research | 2023-09-15 |
| Patiromer Trial in CKD Stage IIIB to V (NCT05786469) | Mario Negri Institute for Pharmacological Research | 2023-08-02 |
| COVID-19 Algorithm Treatment at Home (NCT05413642) | Mario Negri Institute for Pharmacological Research | 2023-07-01 |
| New Analytic Tools for aHUS and C3G Diagnosis (NCT05985122) | Mario Negri Institute for Pharmacological Research | 2023-07-01 |
| Acoustic Analysis of VA Sounds (NCT05612022) | Mario Negri Institute for Pharmacological Research | 2023-05-09 |
| Functional Implications of Rare Gene Mutations in aHUS Open the Door to Personalized Therapy (NCT05805202) | Mario Negri Institute for Pharmacological Research | 2023-05-03 |
| LSCI and Thermography in Diabetic Foot Patients Affected by Ulcer(s): (MY-FOOT-B) (NCT05791929) | Mario Negri Institute for Pharmacological Research | 2023-04-13 |
| Thyroid Hormones in ADPKD (NCT05646420) | Mario Negri Institute for Pharmacological Research | 2023-02-01 |
| Multiparametric MRI in Healthy Volunteers and CKD Patients (NCT05229263) | Mario Negri Institute for Pharmacological Research | 2022-11-25 |
| CardioPulmonary Resuscitation With Argon (CPAr) Trial (NCT05482945) | Mario Negri Institute for Pharmacological Research | 2022-05-30 |
| Anti-inflammatory Drug Algorithm for COVID-19 Home Treatment (NCT05249790) | Mario Negri Institute for Pharmacological Research | 2022-02-24 |
| Obinutuzumab in Primary MN (NCT05050214) | Mario Negri Institute for Pharmacological Research | 2022-02-18 |
| A Prevention Trial of Canakinumab in Subjects at High Risk for Lung Cancer (NCT05725343) | Mario Negri Institute for Pharmacological Research | 2022-02-03 |
| Study on Trabectedin in Combination With Pioglitazone in Patients Myxoid Liposarcomas With Stable Disease After T Alone. (NCT04794127) | Mario Negri Institute for Pharmacological Research | 2022-02-02 |
| Severe Acquired Brain Injuries: Prognostic Factors and Quality of Care (NCT04905264) | Mario Negri Institute for Pharmacological Research | 2022-01-03 |
| Evaluation of the Quality of Care in the Emergency Department by Studying the Appropriateness of Admissions of Patients Accessing the Emergency Department (ASST Papa Giovanni XXIII) (NCT06345378) | Mario Negri Institute for Pharmacological Research | 2021-11-25 |
| Dapagliflozin in Non-diabetic Stage IV CKD (NCT04794517) | Mario Negri Institute for Pharmacological Research | 2021-11-08 |
| MOR202 for Refractory MN (NCT04893096) | Mario Negri Institute for Pharmacological Research | 2021-10-22 |
| Durvalumab and Chemotherapy Induction Followed by Durvalumab and Radiotherapy in Large Volume Stage III NSCLC (NCT04765709) | Mario Negri Institute for Pharmacological Research | 2021-09-24 |
| SGLT2 Inhibitors in Glomerular Hyperfiltration (NCT04143581) | Mario Negri Institute for Pharmacological Research | 2021-09-03 |
| A Simple Approach to Prevent Hospitalization for COVID-19 Patients (NCT04854824) | Mario Negri Institute for Pharmacological Research | 2021-07-01 |
| Health-care Quality in Semi-intensive Care Units (NCT04676347) | Mario Negri Institute for Pharmacological Research | 2021-07-01 |
| Low vs. Standard Daily Doses of Antiepileptic Drugs in Newly Diagnosed, Previously Untreated Epilepsy(STANDLOW) (NCT03689114) | Mario Negri Institute for Pharmacological Research | 2021-05-10 |
| A Simple Approach to Treat COVID-19 Patients at Home. (NCT04794998) | Mario Negri Institute for Pharmacological Research | 2021-02-08 |
| Eculizumab to Cemdisiran Switch in aHUS (NCT03999840) | Mario Negri Institute for Pharmacological Research | 2021-01-01 |
| Selection of People at Low Cardiovascular Risk: Development of an Inexpensive Pre-screening Algorithm Using Only Non-laboratory Measures. The SKIM Risk Study. (NCT03962309) | Mario Negri Institute for Pharmacological Research | 2020-12-18 |
| Early CPAP in COVID-19 Patients With Respiratory Failure. (NCT04326075) | Mario Negri Institute for Pharmacological Research | 2020-12-01 |
| Evaluation of the Quality of Care in the Emergency Department by Studying the Appropriateness of Admissions of Patients Accessing the Emergency Department (Fondazione IRCCS Ca' Granda Ospedale Maggione Policlinico) (NCT06345352) | Mario Negri Institute for Pharmacological Research | 2020-09-15 |
| COVID-19 Impact on the Lombardy Region's Emergency System (NCT04669925) | Mario Negri Institute for Pharmacological Research | 2020-09-01 |
| Prophylactic Surgery Plus HIPEC With CO2 in Patients Affected by Colorectal Carcinoma. CHECK Study. (NCT03914820) | Mario Negri Institute for Pharmacological Research | 2020-06-19 |
| Early CPAP in COVID-19 Patients With Respiratory Failure. A Prospective Cohort Study. (NCT04323878) | Mario Negri Institute for Pharmacological Research | 2020-06-01 |
| Prophylactic Surgery Plus HIPEC With CO2 in Patients Affected by Gastric Carcinoma.GOETH Study (NCT03917173) | Mario Negri Institute for Pharmacological Research | 2020-06-01 |
| Home Care for Patients With COVID-19: Active Monitoring in Two Italian Health Units (Casale Monferrato and Torino) (NCT04361916) | Mario Negri Institute for Pharmacological Research | 2020-04-21 |
| Newton Study (NEW Dosing MainTenance Therapy Ovarian CaNcer) (NCT03891576) | Mario Negri Institute for Pharmacological Research | 2019-11-13 |
| VasQ and Hemodynamic Conditions in AVFs (NCT04141852) | Mario Negri Institute for Pharmacological Research | 2019-10-11 |
| Proton Pump Inhibitors (PPI): a Study to Improve Appropriate Prescriptions in the Elderly (NCT04637750) | Mario Negri Institute for Pharmacological Research | 2019-10-10 |
| Peripheral Artery Disease in Patients With Stable Coronary Artery Disease in General Practice: Prevalence, Management and Clinical Outcomes. (NCT03921905) | Mario Negri Institute for Pharmacological Research | 2019-09-25 |
| Autoreactive B Cells in Membranous Nephropathy (NCT04095156) | Mario Negri Institute for Pharmacological Research | 2019-09-25 |
| Evaluation of ATRA Activity in Combination With Anastrozole in Pre-operative Phase of Operable Early Breast Cancer (NCT04113863) | Mario Negri Institute for Pharmacological Research | 2019-06-18 |
| Real Time Amplitude Spectrum Area to Guide Defibrillation (NCT03237910) | Mario Negri Institute for Pharmacological Research | 2019-04-28 |
| B Cells in Idiopathic Nephrotic Syndrome (NCT05712369) | Mario Negri Institute for Pharmacological Research | 2019-04-02 |
| NASCITA Italian Birth Cohort Study (NCT03894566) | Mario Negri Institute for Pharmacological Research | 2019-04-01 |
| Tolvaptan-Octreotide LAR Combination in ADPKD (NCT03541447) | Mario Negri Institute for Pharmacological Research | 2018-12-12 |
| Non-contrast Enhanced MRI in Patients With C3 Glomerulopathy (C3G) or Immune-complex Membranoproliferative Glomerulonephritis (IC-MPGN) Enrolled in the ACH471-205 Study (NCT03723512) | Mario Negri Institute for Pharmacological Research | 2018-12-06 |
| Insulin Treatment in Diabetic Older People With Heart Failure. (NCT03665350) | Mario Negri Institute for Pharmacological Research | 2018-11-08 |
| Diadem to Investigate the Activity and Safety of Durvalumab (NCT04115111) | Mario Negri Institute for Pharmacological Research | 2018-10-17 |
| Atezolizumab Trial in Endometrial Cancer - AtTEnd (NCT03603184) | Mario Negri Institute for Pharmacological Research | 2018-10-02 |
| Treat_CCM: Propranolol in Familial Cerebral Cavernous Malformation (NCT03589014) | Mario Negri Institute for Pharmacological Research | 2018-04-11 |
| Neoadjuvant Zoledronate and Atorvastatin in Triple Negative Breast Cancer (NCT03358017) | Mario Negri Institute for Pharmacological Research | 2018-03-05 |
| Rheumatoid Arthritis Treatment After First Anti-TNF INvestiGation (NCT03100253) | Mario Negri Institute for Pharmacological Research | 2018-03-01 |
| NEPHSTROM for Diabetic Kidney Disease (NCT02585622) | Mario Negri Institute for Pharmacological Research | 2017-12-11 |
| CoQun Study - (COQUN): a Study to Evaluate the Effects of CoQun in Patients Affected by Open-angle Glaucoma (NCT03611530) | Mario Negri Institute for Pharmacological Research | 2017-09-04 |
| E-learning to Improve Oral Anticoagulant Use in Hospitalized Older People With AF (NCT03188211) | Mario Negri Institute for Pharmacological Research | 2017-09-01 |
| Decision-aid on Breast Cancer Screening (NCT03097653) | Mario Negri Institute for Pharmacological Research | 2017-09-01 |